medical device guru

Biologics, Wound Care, Infection Prevention

Stimlabs® LLC Announces Launch of Relese® – A Uniquely Fenestrated Allograft for Chronic and Acute Wounds

Stimlabs LLC, (“StimLabs”), a leader in regenerative medicine, announced the launch of Relese, a fenestrated dehydrated complete human placental membrane (dCHPM) allograft for chronic and acute wounds. As the latest solution in StimLabs’ growing suite of dCHPM allografts, Relese provides a...

August 28, 2023

Biologics, Wound Care, Infection Prevention

Kerecis to Donate FDA-Approved Fish Skin for Burn Victims of Maui Wildfires

Kerecis®, the company pioneering the use of fish skin and fatty acids for tissue regeneration and protection, is donating its GraftGuide® fish-skin burn product for victims of the fires on Maui, Hawaii. Qualified medical personnel wanting to get fish-skin burn-treatment products...

August 14, 2023

Biologics, Wound Care, Infection Prevention

Allosource Receives FDA 510(K) Clearance for Aceconnex™ Pre-Sutured Fascia for Hip Labral Reconstruction and Augmentation

AlloSource®, one of the largest allograft providers creating innovative cellular and tissue products to help surgeons heal their patients, today announced the U.S. Food and Drug Administration’s 510(K) clearance of AceConnex Pre-Sutured Fascia for hip labral reconstruction and augmentation. This...

July 14, 2023

Biologics, Wound Care, Infection Prevention

Coloplast Announces Agreement to Acquire Kerecis and Raises Long-term Growth Expectations

Coloplast has signed an agreement to acquire Kerecis, an innovative, fast-growing company in the biologics wound care segment, for up to USD 1.3 billion (around DKK 8.9 billion), of which USD 1.2 billion (around DKK 8.2 billion) is an upfront...

July 7, 2023

Biologics, Wound Care, Infection Prevention

Cresilon Receives First FDA Clearance For Human Use of Hemostatic Gel Technology

Cresilon, Inc. (“Cresilon”), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced that it has been granted 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) for Cresilon Hemostatic Gel™ (“CHG™”). This marks Cresilon’s first FDA clearance...

June 30, 2023

Biologics, Wound Care, Infection Prevention

Candela Medical Receives FDA Clearance for Vbeam 595 nm Pulsed Dye Laser, a Treatment for Port Wine Stains and Hemangiomas in Pediatric Cases

Candela Corporation (Candela), a leading global medical aesthetic device company headquartered in Marlborough, MA, today announced that the Vbeam Family of Pulsed Dye Lasers (PDL) has expanded its FDA cleared indications for use of the 595 nm wavelength to include the pediatric...

June 28, 2023

Biologics, Wound Care, Infection Prevention

Cartessa Aesthetics Introduces Helix by DEKA, a Powerful Fusion of Skin Resurfacing Technology

In the growing category of non-invasive, energy-based aesthetic procedures, laser skin resurfacing occupies one of the largest shares. Laser resurfacing is an effective way to reduce the appearance of fine lines, wrinkles, scars, unwanted pigment, and improve skin’s tone and...

May 23, 2023

Biologics, Wound Care, Infection Prevention

Kerecis Combines Fish-Skin Graft and Silicone Cover for Wound Treatment

Kerecis® today announced MariGen® Shield, which integrates the company’s proven fish-skin graft with a silicone contact layer for treating chronic and complex wounds. The medical-fish-skin company also announced the results of a clinical study comparing the effectiveness of the Kerecis fish-skin grafts...

April 28, 2023

Biologics, Wound Care, Infection Prevention

ExtriCARE USA Introduces the extriCARE 3000 Pump to NPWT Market

ExtriCARE USA, is pleased to announce that its innovative extriCARE 3000 pump has received FDA approval for use in the United States. The extriCARE 3000 pump is a state-of-the-art medical device designed to provide versatile and effective wound care treatment...

April 3, 2023